Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC5A2 | P31639 | 9/20 | 0.50 |
| ▸ | SLC5A1 | P13866 | 3/20 | 0.50 |
| ▸ | KDM1A | O60341 | 2/20 | 0.37 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.36 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.35 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.35 |
| ▸ | DRD4 | P21917 | 1/20 | 0.35 |
| ▸ | KCNQ3 | O43525 | 1/20 | 0.35 |
| ▸ | KCNQ2 | O43526 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10041207 | 0.84 | SLC5A2 (0.50) | SLC5A2SLC5A1KDM1AFFAR1KCNQ3 | |
| SCHEMBL1539332 | 0.84 | SLC5A2 (0.50) | SLC5A2SLC5A1KDM1AKMT2ASMN1; SMN2 | |
| SCHEMBL29455231 | 0.79 | SLC5A2 (0.53) | SLC5A2SLC5A1MEN1KMT2A | |
| SCHEMBL1933786 | 0.79 | SLC5A2 (0.53) | SLC5A2SLC5A1MEN1KMT2A | |
| SCHEMBL16601002 | 0.78 | SLC5A2 (0.45) | SLC5A2SLC5A1KDM1AFFAR1KCNQ3 | |
| SCHEMBL27368211 | 0.74 | APP (0.40) | MEN1KMT2A | |
| SCHEMBL15308138 | 0.74 | SLC5A2 (0.47) | SLC5A2SLC5A1 | |
| SCHEMBL16600928 | 0.73 | SLC5A2 (0.41) | SLC5A2SLC5A1KDM1AKCNQ3KCNQ2 | |
| SCHEMBL12257514 | 0.73 | SLC5A2 (0.73) | SLC5A2SLC5A1 | |
| SCHEMBL14954899 | 0.72 | SLC5A2 (0.40) | SLC5A2SLC5A1KDM1AMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113880701-A | Antidiabetic drug intermediate and preparation method thereof | 浙江司太立制药股份有限公司 | 2022-01-04 | — | — | CN | claimed |
| CN-113880701-A | Antidiabetic drug intermediate and preparation method thereof | 浙江司太立制药股份有限公司 | 2022-01-04 | — | — | CN | disclosed |